Feed excerpt — reported by STAT News
German biotech advances a cancer therapy targeting PRAME with striking early results. Now it must prove the treatment works and can succeed commercially.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →